Participants will be recruited from the community and attend a screening clinic and undergo the following screening tests: 1. Bi-parametric MRI - reported by a radiologist and CAD-AI system 2. Multiparametric ultrasound - including shearwave elastography 3. A standard-of-care PSA test A systematic +/- targeted biopsy will be performed if any tests are positive, independent of the other tests.
Study Type
OBSERVATIONAL
Enrollment
411
Imperial College Healthcare NHS Trust
London, United Kingdom
The Proportion of Men With a Positive MRI Defined by a Score of 3 or Greater
Men with a positive MRI defined by a score of 3 or greater
Time frame: Through study completion, an average of 1 month
The Proportion of Men With Screen-positive Prostate MRI Defined by a Score of 4 or Greater
Men With Screen-positive Prostate MRI Defined by a Score of 4 or Greater
Time frame: Through study completion, an average of 1 month
The Proportion of Men With Screen-positive Prostate US Defined by a Score of 3 or Greater
Men With Screen-positive Prostate US Defined by a Score of 3 or Greater
Time frame: Through study completion, an average of 1 month
The Proportion of Men With Screen-positive Prostate US Defined by a Score of 4 or Greater
Men With Screen-positive Prostate US Defined by a Score of 4 or Greater
Time frame: Through study completion, an average of 1 month
The Proportion of Men With Screen-positive PSA Defined by a >/=3ng/ml
Men with screen-positive PSA defined by a \>/=3ng/ml
Time frame: Through study completion, an average of 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.